1.35%| Prev Close: | 34.42 |
|---|---|
| Open: | N/A |
| Bid: | 27.90 x 300 |
| Ask: | N/A |
| 1y Target Est: | 49.00 |
| Beta: | 0.000 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 11.05 - 51.95 |
| Volume: | 0 |
| Avg Vol (3m): | 275,459 |
| Market Cap: | 1.11B |
| P/E (ttm): | N/A |
| EPS (ttm): | -3.44 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The Best Kind of Biotech Dilutionat Motley Fool(Wed, Jun 12)
- Opko: More Hidden Value In Partnerships, Equity Investmentsat Seeking Alpha(Mon, Jun 10)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat, Jun 8)
- The Best- And Worst-Performing Biotech Stocks, May 31 To June 7at Forbes(Sat, Jun 8)
- OPKO Looks Lucrative As Acquired HGH-CTP Moves Into Phase III Trialsat Seeking Alpha(Thu, Jun 6)
- TESARO Details Niraparib Phase 1 Clinical Data Presented at the 2013 ASCO Annual MeetingGlobeNewswire(Tue, Jun 4)
- Double Data, Double Stock Priceat Motley Fool(Mon, Jun 3)
- 1 Biotech + 2 Cancer Drugs = 100% Popat Motley Fool(Mon, Jun 3)
- Why Tesaro Shares Soaredat Motley Fool(Mon, Jun 3)
- Clovis Doubles on Buzz Over Lung Cancer Drugat TheStreet(Mon, Jun 3)
- BioMarin pullback reflects high expectations, says Deutsche Bankat theflyonthewall.com(Mon, Jun 3)
- [video] Mad Money Uncovered: ASCOat TheStreet(Mon, Jun 3)
- Tesaro, BIG, EORTC announce collaboration for niraparibat theflyonthewall.com(Mon, Jun 3)
- TESARO, Breast International Group (BIG), and the European Organization for Research and Treatment of Cancer (EORTC) Announce Collaboration for Niraparib Clinical Development in Breast CancerGlobeNewswire(Mon, Jun 3)
- TESARO and the European Network of Gynecological Oncological Trial Groups (ENGOT) Forge Partnership to Develop Niraparib for Ovarian CancerGlobeNewswire(Mon, Jun 3)
Press Releases
- TESARO Details Niraparib Phase 1 Clinical Data Presented at the 2013 ASCO Annual MeetingGlobeNewswire(Tue, Jun 4)
- TESARO, Breast International Group (BIG), and the European Organization for Research and Treatment of Cancer (EORTC) Announce Collaboration for Niraparib Clinical Development in Breast CancerGlobeNewswire(Mon, Jun 3)
- TESARO and the European Network of Gynecological Oncological Trial Groups (ENGOT) Forge Partnership to Develop Niraparib for Ovarian CancerGlobeNewswire(Mon, Jun 3)
Reports
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(Jun 19)
- ValuEngine Detailed Valuation Report for TSROValuEngine, Inc.(Jun 13)
- TESARO INC (TSRO) Zacks Company SnapshotZacks Investment Research Inc.(Jun 4)